Le Lézard
Classified in: Mining industry, Ebola virus, Business, Covid-19 virus
Subjects: ERP, ACC

SKF Half-year report 2022: Solid growth and increasing price realization helping to mitigate high cost inflation


GOTHENBURG, Sweden, July 20, 2022 /PRNewswire/ -- 

Rickard Gustafson, President and CEO:

"Review of the second quarter

In the second quarter we saw organic revenue growth above 5%, driven by a general strong demand in most regions, especially within targeted high-growth segments, a somewhat higher automotive sales than anticipated and continued price realization.

Growth in Industrial was 6%, with Automotive delivering growth of 3%. Sales to targeted high-growth segments including railway, automation, agriculture, food and beverage continue to develop at a fast pace, with double-digit organic growth.

Net sales were SEK 23,655 million (20,735), on relatively flat sales volumes.

Our adjusted operating profit fell to SEK 2,473 million (3,118), with an adjusted operating margin of 10.5% (15.0%). The Industrial margin was 13.8% (17.4%) and the Automotive margin was 1.7% (9.1%).

The margin development in the quarter was largely a consequence of exceptionally challenging circumstances in April and May. In these two months, the war in Ukraine and the Chinese lockdown impacted our earnings negatively. As a result of these circumstances, material, utilities and logistics costs increased by approximately SEK 600 million compared to Q1. Market conditions in June were more normalized. This, in combination with further price increase realization, resulted in more stable earnings towards the end of the quarter.

Going forward, we maintain our emphasis on controlling costs and increasing prices, delivering continued stronger price realization quarter by quarter.

Cash flow from operations improved sequentially and was SEK 1,293 million (1,372).

Delivering on our strategy

We continue to focus on creating a more customer centric, profitable, faster growing and leaner SKF. In addition to investing in our targeted growth areas and increasing the pace of automation of our factories, we are also making progress in pruning our portfolio. As an example, within Automotive, we have already decided to exit margin-dilutive business with total sales of over SEK 1,200 million, with further pruning to take place as long-term contracts come up for renewal.

The second quarter saw the launch of the RecondOil Box, making our technology available to a wider market. We have already recorded sales of 400 units, with a fast-growing orderbook, especially within heavy industries and energy.

When it comes to factory consolidation, we have announced a further two site closures during the first half of the year. We also completed our previously announced controlled exit from Russia.

To further strengthen and complement our existing industrial seals offer, we have signed an agreement to acquire Tenute, an Italian seals manufacturer.

As we move to the next phase of executing on our strategy, two changes to Group Management have been announced this morning. Patrick Tong (President, Industrial Sales China and Northeast Asia) and Kent Viitanen (President, Industrial Sales EMEA), both of whom have played significant roles in SKF's development in recent years, will be leaving SKF during the third quarter. On behalf of everyone in SKF, I wish them well in the future.

Outlook

Looking into the third quarter of 2022, we expect a high single-digit organic sales growth, with an expected recovery in Automotive demand compared to the same quarter last year.

We expect that the high level of volatility in the markets continues with the ongoing war in Europe, high inflation, a risk for Covid-19 related restrictions across many geographies, supply chain bottlenecks and a volatile demand. For the full year 2022, we maintain our outlook of an organic sales growth of about 4-8%."

Key figures, SEKm unless otherwise stated

Q2 2022

Q2 2021

Half year 2022

Half year 2021

Net sales

23,655

20,735

46,597

40,600

Adjusted operating profit

2,473

3,118

5,531

5,907

Adjusted operating margin, %

10.5

15.0

11.9

14.5

Operating profit

1,581

2,878

4,534

5,577

Operating margin, %

6.7

13.9

9.7

13.7

Adjusted profit before taxes

1,990

3,040

4,979

5,626

Profit before taxes

1,097

2,801

3,982

5,296

Net cash flow from operating activities

1,293

1,372

1,022

1,503

Basic earnings per share

1.08

4.59

5.44

8.50

Adjusted earnings per share

2.90

5.11

7.49

9.23

 

Net sales, change y-o-y, %, Q2

Organic1)

Structure

Currency

Total

SKF Group

5.4

-1.9

10.6

14.1

Industrial

6.4

-1.9

10.5

15.0

Automotive

2.7

-1.9

11.1

11.9

1) Price, mix and volume





 

Net sales, change y-o-y, %, Half year

Organic1)

Structure

Currency

Total

SKF Group

6.1

-1.2

9.8

14.7

Industrial

8.7

-1.3

9.9

17.3

Automotive

0.0

-1.0

9.7

8.7

1) Price, mix and volume





 

Organic sales in local currencies,
change y-o-y, %, Q2

Europe, Middle
East & Africa

The
Americas

China & North-
East Asia

India & South-
 East Asia

SKF Group

5.6

8.7

-8.3

34.7

Industrial

+++

++

--

+++

Automotive

-

++

---

  +++

 

Organic sales in local currencies,
change y-o-y, %, Half year

Europe, Middle
East & Africa

The
Americas

China & North-
East Asia

India & South-
East Asia
 

SKF Group

8.9

8.1

-8.4

24.7

Industrial

+++

+++

-

+++

Automotive

+/-

++

---

+++

 

Outlook and guidance

Demand for Q3 2022 compared to Q3 2021

Looking into the third quarter of 2022, we expect a high single-digit organic sales growth, with an expected recovery in Automotive demand compared to the same quarter last year.

We expect that the high level of volatility in the markets continues with the ongoing war in Europe, high inflation, a risk for Covid-19 related restrictions across many geographies, supply chain bottlenecks and a volatile demand.

Guidance for Q3 2022

Currency impact on the operating profit is expected to be around SEK 350 million positive compared with the third quarter 2021, based on exchange rates per 30 June 2022.

Guidance 2022          

A teleconference will be held on 20 July 2022 at 09:00 (CEST):

Sweden +46 10 884 80 16
UK / International +44 203 936 2999
Passcode: 371618

https://investors.skf.com/en

Aktiebolaget SKF
      (publ)

The financial information in this press release is information which AB SKF is required to disclose under the EU Market Abuse Regulation (EU) No 596/2014 The information was provided by the above contact persons for publication on 20 July 2022 at 08.00 CEST.

For further information, please contact: PRESS: Theo Kjellberg, Director, Press Relations
tel: 46 31 337 6576, mobile: 46 725-776576, e-mail: [email protected]

INVESTOR RELATIONS: Patrik Stenberg, Head of Investor Relations
Patrik Stenberg, 46 31-337 2104; 46 705-472 104; [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/skf/r/skf-half-year-report-2022-solid-growth-and-increasing-price-realization-helping-to-mitigate-high-cos,c3603337

The following files are available for download:

https://mb.cision.com/Main/637/3603337/1606025.pdf

Q2_Eng_final

https://news.cision.com/skf/i/skf-massa---086-png-highpreview-1278-2,c3071620

SKF Massa - 086 png highpreview 1278 2

https://news.cision.com/skf/i/rickard-gustafson,c3071621

Rickard Gustafson

https://news.cision.com/skf/i/skf-recondoil-box-20220401-dsc1255-45b6bf05c461ba-jpeg-fullresolution-1,c3071622

SKF RecondOil Box 20220401 DSC1255-45b6bf05c461ba jpeg fullresolution 1

SOURCE SKF


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 17:15
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...

18 mai 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: